Preparation, Characterization and Anti-Inflammatory Activity of Chitosan Stabilized Silver Nanoparticles

 

S. Ram Prasad*, K. Elango, S. Daisy Chellakumari, S. Dharani

Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-03.

 

 

ABSTRACT:

The present study deals with preparation of silver nanoparticles using green approach such as polysaccharides method. (Chitosan was used as reducing and stabilizing agent). The prepared silver nanoparticles were characterized by UV Visible Spectroscopy, Fourier Transform Infra- red spectroscopy, Photon Correlation Spectroscopy, Scanning Electron Microscope and ICPOES. UV- Visible spectrum shows the SPR band at 420nm which confirms the formation of silver nanoparticles. The average particle size of chitosan stabilized silver nanoparticles was found to be 127.3nm. The amount of silver present in the solution was found to be 1.259mg/L using ICPOES. Chitosan stabilized silver nanoparticles were studied for anti-inflammatory activity. In vitro toxicity studies were carried out in 3T3/NIH fibroblast cell line. Using the natural environmental benign polymer chitosan, the silver nanoparticles were prepared and characterized.

 

KEYWORDS: Chitosan, Silver nanoparticles, SPR band, SEM, ICPOES, Membrane stabilizing activity

 

INTRODUCTION:

Several methods are available for preparation of silver nanoparticles such as polysaccharide, Tollens, Irradiation (Microwave, UV, Gamma etc.,), Biological and Polyoxometalates etc. Based on this approach polysaccharides method was chosen. In this method single polysaccharide plays a dual role as reducing and stabilizing agent.

 

5Chitin is known biodegradable natural polymer based on polysaccharides, which is obtained from crustacean shell (e.g. crab, shrimp, and lobster), some insect (e.g. true fly, Sulphur butterfly) and fungi like yeasts and plants. Chitosan is obtained from partial deacetylation of chitin. Chitosan is a linear polysaccharide comprising copolymers of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit). Chitosan a natural polysaccharide that has unique polycationic, chelating, film forming, reducing, stabilizing properties and various biological properties such as anti-inflammatory, anti-proliferative, anti-oxidant, antimicrobial and anticholesterolemic etc., Chitosan is an abundant, naturally occurring polymer with versatile functionalities. 6

 

7Chitosan is a cationic polyamine with high charge density. It is a linear polyelectrolyte with reactive hydroxyl groups and amino groups. The presence of number of amino groups allow chitosan to react chemically with anionic systems, which results in alteration of physicochemical characteristics of such combinations.

 

 


8Nanocrystalline silver dressings were introduced commercially as antimicrobial dressings in 1998 and these have found to improve wound healing, which may result from potent anti-inflammatory activity. The treatment of murine infected burns with silver nanoparticles was found to increase the rate of healing and decrease the scarring in comparison with silver sulfadiazine. This was accompanied by increased expression of IL-10, vascular endothelial growth factor, and interferon-γ, with reduced IL-6 expression. In a porcine infected wound model, nanocrystalline silver treatments enhanced tissue regeneration while decreasing erythema and edema relative to silver nitrate (AgNO3) treatments. Nanocrystalline silver treatments were also found to increase the polymorphonuclear cell apoptosis while the matrix metalloproteinase (MMP) levels remained low, suggesting an anti-inflammatory effect.

 

In animal models nanocrystalline silver alters the expression of matrix metalloproteinase’s (proteolytic enzymes that are important in various inflammatory and repair processes), suppresses the expression of tumor necrosis factor, Interleukin and induces apoptosis of inflammatory cells. AgNPs modulates cytokine involved in wound healing.

 

The induction of apoptosis by nanocrystalline silver at the dermal cells suggests a highly discriminatory process, related to the unique silver species released (e.g., Ag0), that is different from the indiscriminate activity of Ag+. Silver ions can interfere with the respiratory chain at the cytochromes and can interact with the electron transport chain to activate the intrinsic signaling pathway to apoptosis through the activation of downstream pro-caspases.

 

Nano crystalline silver has anti-inflammatory activity and this is due to the induction of apoptosis in inflammatory cells, and suppression of MMP activity. Nano crystalline silver suppresses the production of proinflammatory cytokines TNF-α, IL-8, and TGF-β, and may impact others, including IL-12. Over expression of MMPs includingMMP-2 and MMP-9 contributes to tissue injury and inflammation. Therefore, MMP inhibition has been suggested as a therapeutic approach to controlling inflammation and the similarities between the model system and human skin suggests the use of silver nanoparticles for as better anti-inflammatory agent. Therefore it is of interest to prepare silver nanoparticles using chitosan to treat inflammation.

 

EXPERIMENTAL METHODS:

Materials:

Chitosan 85% deacetylated was obtained as gift sample from Central Institute of Fisheries Technology, Kochi. Silver Nitrate (99%) was purchased from Sigma Aldrich (Analytical Grade). Deionized water was used in this experiment. All the other chemicals were of analytical grade.

 

Synthesis of Silver Nanoparticles: 9, 10

50 ml of 0.1% chitosan solution was preheated at 80ºC±2ºC for 30 minutes. 10ml aqueous solution of 0.1 M Silver nitrate was added to the above solution. The mixture was transferred to a magnetic stirrer and the temperature was maintained at 60ºC±2ºC, 70ºC±2ºC, and 80ºC±2ºC and any colour  change was noted.  Colloidal silver nanoparticles exhibit absorption at wavelength from 380-420nm due to Mie scattering Theory. The colour change was noted and analyzed by UV Visible spectrophotometer.

 

In order to reduce Silver nitrate to NanoSilver, various concentrations of silver nitrate (1mM, 2mM, 3mM, 4mM, 5mM & 0.1M) were added to 0.1%  chitosan solution. The optimal concentration of silver nitrate to form silver nanoparticles was determined.

 

CHARACTERIZATION:

UV- Visible Spectroscopy:

Synthesized chitosan stabilized silver nanoparticles were scanned in the range of 200-800nm using UV –Visible Spectrophotometer , UV 1800, Shimadzu, Japan.

 

Fourier Transformation Infrared Spectroscopy:

FTIR spectrum of Chitosan and Chitosan Stabilized Silver nanoparticles spectrum were  recorded using Nicolet Fourier transformation Infrared spectroscopy (FT-IR) combined to PC (with spectrum 2000 analysis software) in the range of 4000 cm-1 to 400 cm-1 by Potassium Bromide Press Pellet technique .The pellet was placed in light path and the spectra were analyzed.

 

Malvern particle size analyzer:

The sample of the optimized chitosan stabilized nanoparticle was analyzed for particle size using Malvern Zetasizer. The particle size, their range and degree of distribution were studied using this analyzer. The nanosuspension was diluted 10 fold with millipore water. The diluted solution was used for the analysis. The size of the particle was measured based on the scattering of laser light by the particle. The angular intensity of the scattered light was then measured by a series of photosensitive detectors. The map of scattering intensity versus angle is the primary source of information used to calculate the particle size.

 

Inductively Coupled Plasma Optical Emission Spectroscopy (ICPOES): 

The amount of silver content present in the nanosuspension was analyzed by Perkin Elmer Optima 5300 DV ICP-OES. It is a most widely used analytical technique for measuring concentrations of major, minor and trace elements. It is a robust analytical method capable of providing analyzes for a wide range of elements in a diversity of sample matrices.

 

Scanning electron microscopy:

The particle size of the optimized nanoparticles was viewed and photographed using scanning electron microscope. The nano suspension of AgNPs was diluted 10 fold with millipore water and transferred to a glass slide which was cut in the diameter of 20×20mm. The slide was mounted on an aluminum stub using double sided carbon tape. The solution was slowly evaporated at room temperature. The completely dried sample was coated with gold by sputter coating unit at 10 Pascal vacuum for 10 second to a thickness of 100 A° using HITACHI evaporator. The image was captured on SEM mode at desired magnification.

 

MEMBRANE STABILIZING ACTIVITY: 11, 12

Preparation of Human Red Blood Cells (HRBC) Suspension:

Fresh whole human blood was collected and mixed with equal volume of isotonic saline (0.85%).  The blood was centrifuged at 3000 rpm for 10 min and packed cells were washed three times with isotonic saline (0.85%, pH 7.2). The volume of the blood was measured and reconstituted as 10% v/v suspension with isotonic saline.

 

Heat Induced Hemolysis:

The principle involved here is stabilization of human red blood cell membrane by hypo tonicity induced membrane lysis. The reaction  mixture contains 1ml phosphate buffer [pH 7.4], 2 ml hypo saline [0.36 %], 0.5 ml HRBC suspension [10 % v/v] with 0.5 ml of test solutions(Chitosan Stabilized AgNPs) and standard drug Diclofenac sodium (50mg) and control (distilled water instead of hypo saline to produce 100 % Hemolysis). They were incubated at 56ºC for 30 minutes. The tubes were cooled under running tap water for 20 minutes. The mixtures were centrifuged and the absorbance of the supernatants read at 560 nm.

 

The percentage of Hemolysis of HRBC membrane is calculated as follows:

                      100- (O.D. of test – O.D. of product control)

Percent Stabilization =                                                             x 100

                                      O.D. of Control

 

In vitro Toxicity Studies of Silver Nanoparticles in 3T3 NIH Fibroblast cell line:  13, 14

Cell line:

3T3 NIH Fibroblast cell lines were obtained from National Centre for Cell sciences, Pune (NCCS). The cells were maintained in Minimal Essential Media supplemented with 10% FBS (Fetal Bovine Serum), penicillin (100 U/ml), and streptomycin (100 μg/ml) in a humidified atmosphere of 50 μg/ml CO2 at 37 °C.). 

 

Reagents:

MEM was purchased from Hi Media Laboratories Fetal bovine serum (FBS) was purchased from (Cistron laboratories) Trypsin, methylthiazolyl diphenyl- tetrazolium bromide (MTT), and Dimethyl sulfoxide (DMSO) were purchased from (Himedia).

 

In vitro assay for Cytotoxicity activity (MTT assay):

The Cytotoxicity of samples on 3T3 NIH fibroblast was determined by the MTT assay.  Cells (1 × 105/well) were placed in 100 μl of medium/well in 96-well plates (Costar Corning, Rochester, NY). After 48 hours of incubation the cell reaches the confluence. Then, cells were incubated in presence of various concentrations of the samples (Silver nanoparticles) in 0.1% DMSO for 48h at 37°C.The sample solution was washed with phosphate-buffered saline (pH 7.4), 20µl/well (5mg/ml) of 0.5% 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl--tetrazolium bromide cells(MTT) in phosphate- buffered saline solution was added. After 4 hours of incubation, 1ml of DMSO was added. Viable cells were determined by the absorbance at 540nm. Measurements were performed and the concentration required for a 50% inhibition of viability (IC50) was determined graphically. The effect of the samples on the proliferation of fibroblast cells was expressed as the % cell viability.

% cell viability = A540 of treated cells / A540 of control cells × 100

 

RESULTS & DISCUSSION:

Preparation of Silver nanoparticles:

Silver nanoparticles were prepared using various concentration of silver nitrate at different temperatures. The optimum concentration of was found to be 0.1M silver nitrate solution. During reduction of silver nitrate colour change was noted. Initially it was pale yellow colour and turns to yellowish brown colour at the end of 2 hours which shows the formation of AgNPs at 80ºC ± 2 ºC and the resulting solutions were scanned by UV –Visible spectrophotometer. The observation is shown in table: 1.

 

Table: 1 Optimization of temperature for preparation of silver nanoparticles

Volume of 0.1% Chitosan

Volume of 0.1M Silver Nitrate

Temperature

Observation

100 ml

10 ml

60ºC ± 2ºC

No Change in colour

70ºC ± 2ºC

No Change in colour

80ºC ± 2 ºC

Yellowish Brown colour

 

UV –Visible Spectroscopy:

Surface Plasmon Resonance band during reduction of Silver nanoparticles: 15

Silver nanoparticles were prepared by controlled heating technique samples were withdrawn at half an hour interval & analyzed in UV Visible Spectrophotometer. Colloidal silver nanoparticles exhibit absorption at wavelength from 380-420nm due to Mie scattering Theory. The absorption maxima at 420 nm which confirms the formation of silver nanoparticles. The overlay spectrum of absorption maxima of silver nanoparticles are shown in the Figure: 1.

 

Figure: 1 Overlay spectrum of AgNPs (λmax at 60minutes, 90minutes & 120minutes)

ICPOES:

The amount of silver in the pellets obtained after centrifugation is estimated by ICPOES. The amount of Silver in colloidal silver solution was found to be 1.259mg/L.

 

Particle Size of Silver nanoparticles:

The Particle size distribution of chitosan stabilized silver nanoparticles is shown in the Figure: 2. The spectrum shows that the maximum number of silver nanoparticles in the range of 127.3 nm.

 

Scanning Electron Microscopy:

The SEM image of chitosan stabilized silver nanoparticles was shown in Figure: 3. The silver nanoparticles were spherical in shape and uniform in size.

 

Fourier Transform Infrared Spectroscopy: 16

FTIR spectra of chitosan and chitosan Silver nanoparticles are shown in the Figures 4 & 5. A peak at 3440 cm-1 indicates the combined peaks of OH and NH2 group (stretching vibrations of chitosan). In Chitosan stabilized silver nanoparticles a shift from 3440 cm-1 to 3325 cm-1 show the reduced hydrogen bonding. A peak at 1651 cm-1 disappears and a new peak appears at 1632 cm-1 shows the attachment of silver with Nitrogen atoms, which reduces vibration intensity of the N-H bond due to the molecular weight becoming greater after silver binding.

 

In vitro Toxicity of Silver Nanoparticles in 3T3 NIH fibroblast Cells:

From the morphology of cells and MTT assay concentration of upto 7.8 μg/ml indicates 91.4% cells are viable. Hence the prepared AgNPs were found to be biocompatible and non-toxic as shown in Table 2.


 

Figure: 2 Particle size distributions of AgNPs

Figure: 3 SEM image of Silver nanoparticles

Figure: 4 FTIR spectra of Chitosan

 

Figure: 5 FTIR spectrum of Silver Nanoparticles

Table: 2 Percentage of Cell viability of fibroblast cell on addition of AgNPs

S. No.

Concentration    µg/ml

Dilution

Absorbance    540nm

% cell Viability

1

1000

Neat

0.18

25.7

2

500

1:1

0.22

31.4

3

250

1:2

0.29

41.4

4

125

1:4

0.35

50.0

5

62.5

1:8

0.43

61.4

6

31.2

1:16

0.49

70.0

7

15.6

1:32

0.56

80.0

8

7.8

1:64

0.64

91.4

9

control

-

0.70

100

 

 

Figure:6  Percentage Cell Viability at various concentrations μg/ml

 


 

Figure 6 represents that percentage cell viability against concentration of silver nanoparticles. Figure 7 shows that surface morphology of Fibroblast Cells with various concentrations of Chitosan Stabilized Silver nanoparticles

 

Figure: 7 In vitro Toxicity of Silver Nanoparticles in 3T3 NIH fibroblast Cells

 

MEMBRANE STABILIZING ACTIVITY

The prepared Chitosan stabilized silver nanoparticles were tested for membrane stabilizing activity. Percentage stabilization was 62.74 for AgNPs and 78.21 for standard drug Diclofenac Sodium (Figure: 8). The percentage stabilization of silver nanoparticles was good when compared with the standard drug.

 

Figure: 8 Membrane Stabilizing activity (T1 – AgNPs, S- Standard Drug)

 

CONCLUSION:

The silver nanoparticles were prepared using environmental benign natural polymer Chitosan (85% deacetylated) using green chemistry. The optimum concentration of silver nitrate required to form silver nanoparticles was found to be 0.1M AgNO3. In controlled heating technique, the stable silver nanoparticles were formed at 80ºC±2ºC for 2 hours. The in vitro toxicity studies normal fibroblast cells show the biocompatibility and non toxicity of AgNPs. As the chitosan and silver have multifunctional properties, the AgNPs reduced with chitosan may be a better therapeutic agent to treat inflammation/inflammatory sites. Silver nanoparticles have anti-inflammatory and antibacterial property. Chitosan is uused as anti-inflammatory, antioxidant, reducing and stabilizing agent. The chitosan stabilized silver nanoparticles produce synergistic effect to treat inflammation.

 

ACKNOWLEDGEMENT:

I acknowledge my special thanks to Central Institute of Fisheries Technology, Kochi, for providing Chitosan as gift sample. It’s my privilege to thank The Director, National Centre for Cell sciences, Pune for their material assistance of 3T3 /NIH fibroblast cell line .I extend my sincere thanks to my Professor and Head, Staff Members, Friends and Family members for their support and encouragement.

 

REFERENCES:

1.       Vicky V. Mody, Rodney Siwale, Ajay Singh, and Hardik R. Mody. Introduction to Metallic Nanoparticles. Journal of Pharmacy & Bio Allied Sciences. 2(4); 2009: 282-289.

2.       Paz Sevilla, Raquel De-Llanos, Concepcion Domingo, Santiago Sanchez- Cortes, Joes V. SERS+MEF of the anti tumoral drug emodin adsorbed on silver nanoparticles. Proceedings of SPIE (Society of Photographic Instrumentation Engineers). 7577, 757714; 2011:1 -5.

3.       Purest colloid: History of Silver and Colloidal Silver. Available from: URL: http://www.purestcolloids.com/

4.       Virender K. Sharma, Ria A. Yngard, Yekaterina Lin. Silver Nanoparticles: Green synthesis and their antimicrobial activities. Advances in colloid and Interface Science. 145; 2009:83-96.

5.       Inmaculada Aranaz, Ruth Harris and Angeles Heras. Chitosan Amphiphilic Derivatives. Chemistry and Applications. Current organic Chemistry. 14; 2010:308-330.

6.       Vivek Jain, Gopal Garg, U.K. Patil and Shailesh Jain. Recent Perspectives of Chitosan: A Review. Research Journal of Pharmaceutical Dosage Form and Technology. 2(3); 2010:220.

7.       Raymond C Rowe, Paul J Sheskey and Marian E Quinn, Chitosan. Hand book of Pharmaceutical Excipients. Pharmaceutical Press, London. 2009; 6th Ed: pp. 159- 162.

8.       Vaidyanathan, R., Kalimuthu Kalishwaralal, Shubaash Gopalram, Sangiliyandi Gurunathan.  Nanosilver -The burgeoning therapeutic molecule and its green synthesis. Biotechnology Advances. 27; 2009:924-937.

9.       Mansor Bin Ahmad, Jenn Jye Lim, Kamyar Shameli, Nor Azowa Ibrahim and Mei Yen Tay. Green Synthesis and Characterization of Silver/Chitosan/Polyethylene Glycol Nanocomposites without any reducing agent. International Journal of Molecular Sciences. 12; 2011: 4872-4884.

10.    Hoang Vinh Tran, Lam Dai Tran,_, Cham Thi Ba, Hoang Dinh Vu, Thinh Ngoc Nguyen,Dien Gia Phamc, Phuc Xuan Nguyenet.  Synthesis, Characterization, antibacterial and anti-proliferative activities of monodisperse chitosan-based silver nanoparticles. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 360; 2010:32-40.

11.    Seema Chaitanya Chippadaand Meena Vangalapati.  Antioxidant, an anti-inflammatory and anti-arthritic activity of Centella asiatica extracts. Journal of Chemical, Biological and Physical Sciences.1 (2) Sec. B; 2011: 260-269.

12.    Lavanya .R.  S Uma Maheshwari, G Harish, J Bharath Raj, S Kamali, D Hemamalani  et al. Investigation of In-vitro anti-Inflammatory, anti-platelet and anti-arthritic activities in the leaves of Anisomeles malabarica Linn. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 1(4); 2010:745-752.

13.    Han, Dongoh, Hee-Young Kim, Hye-Jung Lee1, Insop Shim, and Dae-Hyun Hahmet.  Wound Healing Activity of Gamma-Aminobutyric Acid (GABA) in rats. Journal of Microbiology and Biotechnology. 17(10); 2007:1661-1669.

14.    Moul Dey, David Ribnicky, Anvar G. Kurmukov, and Ilya Raskin.  In Vitro and in vivo anti-inflammatory activity of a seed preparation containing Phenethylisothiocyanate. The Journal of Pharmacology and Experimental Therapeutics. 317(1); 2006: 326-333.

15.    Kiruba Daniel S.C.G. Anitha Sironmani, V Tharmaraj, and K Pitchumanil. Synthesis and Characterization of Fluorophore attached silver nanoparticles. Bull Material Science. 34(4); 2011: 639-643.

16.    Dongwei Wei, Wuyong Sun, Weiping Qian, Yongzhong Ye, Xiaoyuan Ma. The synthesis of Chitosan-based silver nanoparticles and their antibacterial activity. Carbohydrate Research. 344; 2009: 2375-2382.

 

Received on 03.04.2013

Modified on 03.05.2013

Accepted on 12.05.2013     

© A&V Publication all right reserved

Research Journal of Pharmaceutical Dosage Forms and Technology. 5(3): May- June, 2013, 161-167